payment crypto coins- Top Related searches

The Ministry of Human Resources and Social Security and other five departments: the situation of receiving personal pensions in advance was added. On December 12, the Ministry of Human Resources and Social Security and other five departments issued the Notice on the Full Implementation of the Personal Pension System. The circular calls for optimizing the supply of products, and on the basis of existing financial products such as wealth management products, savings deposits, commercial pension insurance and Public Offering of Fund, specific pension savings and index funds will be included in the catalogue of personal pension products. The notice also increased the situation of receiving the pension in advance. In addition to reaching the age of receiving the basic pension, completely losing the ability to work, and going abroad to settle down, participants who suffer from serious diseases, receive unemployment insurance benefits to certain conditions, or are receiving the minimum living allowance can apply for receiving the personal pension in advance. (Xinhua News Agency)Yunnan Germanium Industry: downstream customers didn't feedback that the company germanium was directly used in quantum chip products. Some investors asked Yunnan Germanium Industry (002428) on the interactive platform: in quantum computing and quantum communication, germanium is widely used in the manufacturing process of quantum chips, which can achieve excellent performance. Excuse me, does the company have germanium products used in quantum chips? Yunnan Germanium Industry replied that at present, the downstream customers of the company have not reported to the company that it is directly used in this product.In 2024, the qualification examination and approval of the first batch of new materials insurance compensation was started, and the Ministry of Industry and Information Technology recently issued a notice to organize the qualification examination and approval of the first batch of new materials insurance compensation in 2024. It is clear that the enterprise applying for qualification should be an enterprise that produces and manufactures the products listed in the Catalogue for the Demonstration and Guidance of the First Application of Key New Materials (2024 Edition). It belongs to an independent legal person registered in People's Republic of China (PRC), has strong design and development, manufacturing and industrialization capabilities, has a relatively complete team of professional technicians, and has mastered the core technology and intellectual property rights of this product development. The qualification examination and approval procedures need to go through three steps: enterprise declaration, review by local industrial and information authorities or recommended units such as the central enterprise group, and expert review organized by the Ministry of Industry and Information Technology. After review, the product compensation qualification is determined, and the amount of subsidy funds is approved according to a certain proportion of the product value, and the effective period is no more than 3 years.

The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.The venue of the 2030 and 2034 FIFA World Cups was confirmed. On the 11th, FIFA held a special meeting online, attended by all 211 FIFA member associations. The Congress confirmed that the 2030 Men's Football World Cup will be jointly hosted by Morocco, Portugal and Spain, and the 2034 Men's Football World Cup will be held in Saudi Arabia. After multi-party coordination, there is only one bidder left in the two World Cups, so there is no suspense in the final result. At the same time, the conference confirmed that 2030 coincides with the centenary of the first World Cup, and FIFA decided to hold a 2030 World Cup in Uruguay, Argentina and Paraguay, respectively, to celebrate the centenary of the World Cup.Market News: Brian Quintenz has become the top contender for the chairmanship of the Commodity Futures Trading Commission (CFTC).

Evergrande Group and others were resumed execution by 320 million yuan. According to the information of legal proceedings, on December 11th, Evergrande Group Co., Ltd. added two pieces of resumption execution information, with a total execution amount of more than 322 million yuan, involving construction project contract disputes. The executors also included Hefei Yuetai Commercial Operation Management Co., Ltd. and Evergrande Real Estate Group Co., Ltd., and the enforcement court was the Baohe District People's Court in Hefei.The Chinese medicine sector collectively pulled up Panlong Pharmaceutical's linear daily limit, Panlong Pharmaceutical's linear daily limit, Xiangxue Pharmaceutical, Kunyao Group, Huasen Pharmaceutical, Jingxin Pharmaceutical, Xinguang Pharmaceutical and Changyao Holdings followed suit.The Nikkei 225 index closed at 39,881.10 points in early trading, up 1.29%.